S. 3269: Cannabidiol Research Expansion Act

A bill to require the Attorney General to make a determination as to whether cannabidiol should be a controlled substance and listed in a schedule under the Controlled Substances Act and to expand research on the potential medical benefits of cannabidiol and other marijuana components.

The bill’s titles are written by its sponsor.

What you can do



Jul 14, 2016


Referred to Committee on Jul 14, 2016

This bill was assigned to a congressional committee on July 14, 2016, which will consider it before possibly sending it on to the House or Senate as a whole.


Dianne Feinstein

Senior Senator from California



Read Text »
Last Updated: Jul 14, 2016
Length: 12 pages


1% chance of being enacted according to PredictGov (details)


Jul 14, 2016

This is the first step in the legislative process.

Reported by Committee

Passed Senate

Passed House

Signed by the President

S. 3269 is a bill in the United States Congress.

A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.

How to cite this information.

We recommend the following MLA-formatted citation when using the information you see here in academic work:

“S. 3269 — 114th Congress: Cannabidiol Research Expansion Act.” www.GovTrack.us. 2016. October 28, 2016 <https://www.govtrack.us/congress/bills/114/s3269>

Where is this information from?

GovTrack automatically collects legislative information from a variety of governmental and non-governmental sources. This page is sourced primarily from Congress.gov, the official portal of the United States Congress. Congress.gov is generally updated one day after events occur, and so legislative activity shown here may be one day behind. Data via the congress project.